No Data
A Quick Look at Today's Ratings for Tandem Diabetes Care(TNDM.US), With a Forecast Between $27 to $50
Tandem Diabetes Price Target Raised to $35 From $30 at BofA
Analysts Offer Insights on Healthcare Companies: Vir Biotechnology (VIR), Tandem Diabetes Care (TNDM) and Hims & Hers Health (HIMS)
Express News | Tandem Diabetes Care Inc : BofA Global Research Raises Price Objective to $35 From $30
Trending Stocks Today | Reliance Global Rises 14.74% Post-Market
Tandem Diabetes Care Announces $200M Notes Offering